Back to Search Start Over

Cost-effectiveness of a participatory return-to-work intervention for temporary agency workers and unemployed workers sick-listed due to musculoskeletal disorders: design of a randomised controlled trial.

Authors :
Vermeulen SJ
Anema JR
Schellart AJ
van Mechelen W
van der Beek AJ
Vermeulen, Sylvia J
Anema, Johannes R
Schellart, Antonius J M
van Mechelen, Willem
van der Beek, Allard J
Source :
BMC Musculoskeletal Disorders. 2010, Vol. 11, p60-60. 1p.
Publication Year :
2010

Abstract

<bold>Background: </bold>Within the working population there is a vulnerable group: workers without an employment contract and workers with a flexible labour market arrangement, e.g. temporary agency workers. In most cases, when sick-listed, these workers have no workplace/employer to return to. Also, for these workers access to occupational health care is limited or even absent in many countries. For this vulnerable working population there is a need for tailor-made occupational health care, including the presence of an actual return-to-work perspective. Therefore, a participatory return-to-work program has been developed based on a successful return-to-work intervention for workers, sick-listed due to low back pain.The objective of this paper is to describe the design of a randomised controlled trial to study the (cost-)effectiveness of this newly developed participatory return-to-work program adapted for temporary agency workers and unemployed workers, sick-listed due to musculoskeletal disorders, compared to usual care.<bold>Methods/design: </bold>The design of this study is a randomised controlled trial with one year of follow-up. The study population consists of temporary agency workers and unemployed workers sick-listed between 2 and 8 weeks due to musculoskeletal disorders. The new return-to-work program is a stepwise program aimed at making a consensus-based return-to-work implementation plan with the possibility of a (therapeutic) workplace to return-to-work. Outcomes are measured at baseline, 3, 6, 9 and 12 months. The primary outcome measure is duration of the sickness benefit period after the first day of reporting sick. Secondary outcome measures are: time until first return-to-work, total number of days of sickness benefit during follow-up; functional status; intensity of musculoskeletal pain; pain coping; and attitude, social influence and self-efficacy determinants. Cost-benefit is evaluated from an insurer's perspective. A process evaluation is part of this study.<bold>Discussion: </bold>For sick-listed workers without an employment contract there can be gained a lot by improving occupational health care, including return-to-work guidance, and by minimising the 'labour market handicap' by creating a return-to-work perspective. In addition, reduction of sickness absence and work disability, i.e. a reduction of disability claims, may result in substantial benefits for the Dutch Social Security System.<bold>Trial Registration: </bold><bold>Trial Registration Number: </bold>NTR1047. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
14712474
Volume :
11
Database :
Academic Search Index
Journal :
BMC Musculoskeletal Disorders
Publication Type :
Academic Journal
Accession number :
105182565
Full Text :
https://doi.org/10.1186/1471-2474-11-60